Biote Corp (BTMD)
6.01
+0.23
(+3.98%)
USD |
NASDAQ |
May 03, 16:00
6.02
+0.01
(+0.17%)
After-Hours: 20:00
Biote Free Cash Flow (Quarterly): 5.952M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.952M |
| September 30, 2023 | -0.324M |
| June 30, 2023 | 5.93M |
| March 31, 2023 | 12.61M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.74M |
| September 30, 2022 | 6.006M |
| June 30, 2022 | -29.23M |
| March 31, 2022 | 6.487M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-29.23M
Minimum
Jun 2022
12.61M
Maximum
Mar 2023
1.647M
Average
5.941M
Median
Free Cash Flow (Quarterly) Benchmarks
| Teladoc Health Inc | -26.59M |
| American Shared Hospital Services | -3.157M |
| Novo Integrated Sciences Inc | -1.714M |
| Astrana Health Inc | 12.24M |
| Cryo-Cell International Inc | -0.8146M |